BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17601910)

  • 1. Endometrial expression of Cyr61: a marker of estrogenic activity in normal and abnormal endometrium.
    MacLaughlan SD; Palomino WA; Mo B; Lewis TD; Lininger RA; Lessey BA
    Obstet Gynecol; 2007 Jul; 110(1):146-54. PubMed ID: 17601910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyr61 suppresses growth of human endometrial cancer cells.
    Chien W; Kumagai T; Miller CW; Desmond JC; Frank JM; Said JW; Koeffler HP
    J Biol Chem; 2004 Dec; 279(51):53087-96. PubMed ID: 15471875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.
    Balmer NN; Richer JK; Spoelstra NS; Torkko KC; Lyle PL; Singh M
    Mod Pathol; 2006 Dec; 19(12):1593-605. PubMed ID: 16980945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium.
    Gregory CW; Wilson EM; Apparao KB; Lininger RA; Meyer WR; Kowalik A; Fritz MA; Lessey BA
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2960-6. PubMed ID: 12050280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
    Ma XX; Zhang SL; Gao S; Lu JM; Dong F
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression index of estrogen receptor alpha mRNA isoforms in simple, complex hyperplasia without atypia, complex atypical hyperplasia and adenocarcinoma.
    Witek A; Paul-Samojedny M; Stojko R; Seifert B; Mazurek U
    Gynecol Oncol; 2007 Aug; 106(2):407-12. PubMed ID: 17561234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
    Villavicencio A; Bacallao K; Avellaira C; Gabler F; Fuentes A; Vega M
    Gynecol Oncol; 2006 Oct; 103(1):307-14. PubMed ID: 16677694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
    Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoid receptors in the human endometrium and its disorders: a possible modulator of 17 beta-hydroxysteroid dehydrogenase.
    Ito K; Suzuki T; Moriya T; Utsunomiya H; Sugawara A; Konno R; Sato S; Sasano H
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2721-7. PubMed ID: 11397877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
    Zhou XH; Teng XD; Song WY; Wu YJ
    Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma.
    Shroyer KR; Stephens JK; Silverberg SG; Markham N; Shroyer AL; Wilson ML; Enomoto T
    Int J Gynecol Pathol; 1997 Jul; 16(3):225-32. PubMed ID: 9421087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.
    Bircan S; Ensari A; Ozturk S; Erdogan N; Dundar I; Ortac F
    Pathol Oncol Res; 2005; 11(1):32-9. PubMed ID: 15800680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
    Watari H; Xiong Y; Hassan MK; Sakuragi N
    Gynecol Oncol; 2009 Jan; 112(1):229-34. PubMed ID: 19007976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
    Zhang SQ; Cai B; Liu L; He YY; Yang YX; Wan XP
    Int J Gynecol Cancer; 2009 Nov; 19(8):1377-83. PubMed ID: 20009893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Expression of IR-A, IR-B and IGF-1R in Endometrial Physiology and Distinct Signature in Adenocarcinoma.
    Flannery CA; Saleh FL; Choe GH; Selen DJ; Kodaman PH; Kliman HJ; Wood TL; Taylor HS
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2883-91. PubMed ID: 27088794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premenstrual regulation of the pro-angiogenic factor CYR61 in human endometrium.
    Gashaw I; Stiller S; Böing C; Kimmig R; Winterhager E
    Endocrinology; 2008 May; 149(5):2261-9. PubMed ID: 18202125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
    Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
    Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extracellular signal-regulated protein kinase activation in endometrium with polycystic ovary syndrome and its significance].
    Song XR; Zhang HY; Zhang YF; Han YK; Li KJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):767-71. PubMed ID: 21176559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.
    Deng L; Broaddus RR; McCampbell A; Shipley GL; Loose DS; Stancel GM; Pickar JH; Davies PJ
    Clin Cancer Res; 2005 Dec; 11(23):8258-64. PubMed ID: 16322283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.